It was reported that on (b)(6) 2024, a mitraclip procedure was performed to treat functional mitral regurgitation (mr) grade 4.The patient presented with a pre-existing pericardial effusion.The steerable guide catheter (sgc) was inserted successfully.The xtw clip delivery system (cds) was then inserted into the sgc and straddled confirmed.When steering towards the valve on the cds, resistance with the medial (m)/lateral (l) knob was noted.M-knob was removed.It was then noted that the pericardial effusion had worsened.The effusion was located at the posterior wall of the left atrium.The mitraclip cds and sgc were removed from the patient and pericardiocentesis was performed successfully.It was ultimately decided to move the patient to surgery to complete the valve repair, the effusion was repaired as well.The patient had a prolonged stay in the intensive care unit (icu).
|
The device was not returned for analysis.A review of the lot history record revealed no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Additionally, a review of the complaint history identified no similar complaints reported from this lot.The investigation was unable to determine a cause for the reported resistance of the knob and pericardial effusion.Pericardial effusion is listed in the instructions for use as a known possible complication associated with the mitraclip procedures.The reported off-label use was due to the triclip steerable guide catheter (tsgc) being used on a mitral valve.The reported unexpected medical intervention, surgical intervention, and hospitalization were results of case specific circumstances.There is no indication of a product issue with respect to manufacture, design, or labeling.
|